GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Restart Life Sciences HEAL.CN · CAD

Health Care · Canadian Securities Exchange · 🇨🇦 Canada

Compare

0.07

-18.75%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Restart Life Sciences — daily HEAL

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Restart Life Sciences on TradingView ↗
Market value
C$693,160
Last close × shares
Volume
170.5k
Shares, 9 Nov 2026

About Restart Life Sciences

Its shares trade on Canadian Securities Exchange under the ticker HEAL.CN. It has been listed since 22 September 2006. In the fiscal year to 31 December 2020, it reported revenue of C$11,500 and a net loss of C$25.2m. At that date it held total assets of C$3.0m and shareholders' equity of C$2.7m.

Nova Mentis Life Science Corp. is a biotechnology company, which engages in building and supporting a diversified portfolio of cannabis-sector businesses. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2006-09-22. The firm is engaged in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. The firm has orphan drug designation in both the United States and European Union for the use of psilocybin in the treatment of fragile X syndrome (FXS). Its focus is to diagnose and treat debilitating chronic conditions that have unmet medical needs, such as autism spectrum disorder (ASD) and FXS. Its core scientific focus is on chronic neuroinflammatory conditions, which fall under three categories: neurodevelopmental, neurometabolic, and neurodegenerative. The firm operates in one segment, being research and development of psilocybin, and in one geographic area, being Canada, through its wholly owned subsidiaries, Nova Mentis Biotech Corp., and SwabAi Diagnostics Inc.

Figures and description from our data supplier, not checked against the company's own report.

More about Restart Life Sciences →

Latest on Restart Life Sciences

Our reporting

We have not reported on Restart Life Sciences yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Restart Life Sciences's ticker?

Restart Life Sciences trades as HEAL.CN on Canadian Securities Exchange, under ISIN CA76134J2065.

What was Restart Life Sciences's last closing price?

0.07 on 9 Nov 2026. The figure is in CAD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.